Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Reviva Pharmaceuticals Holdings Inc
RVPH
Healthcare
Biotechnology
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company’s lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications,...
including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer’s disease, and Parkinson’s disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:RVPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(5)
•••
Adwari
X
Post by
Adwari
on Jan 23, 2025 6:23pm
Have they closed the $18 million public offering?
Just wondering because I don't see any news release that it was closed.
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 1:57pm
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH): A Late-
https://beyondspx.com/2024/07/31/reviva-pharmaceuticals-holdings-inc-nasdaqrvph-a-late-stage-biopharma-advancing-novel-therapies-for-unmet-needs/
BioVaxys & Adiverna Enter Collaboration to Develop Companion Animals Vaccines
posted Mar 10, 2026 9:00am by
BioVaxys Technology Corp.
-
|
“We are very excited to be working with Adiverna to develop what could be the world’s first mRNA veterinary vaccine. We believe the clinically proven advantages of the DPX platform formulated with Adiverna’s AI-designed mRNA sequences will provide for a superior product, adds Kovan. “With demonstrated in vivo proof of concept of DPX mRNA formulations, this ‘proof of product’ will further our partnering discussions utilizing DPX mRNA formulations in human therapeutic applications.” ...read more
(0)
•••
Univego
X
Post by
Univego
on Apr 20, 2023 1:33am
Saturday,Reviva on Bloomberg TV
https://www.accesswire.com/750110/Reviva-Pharmaceuticals-Holdings-Inc-Interview-to-Air-on-Bloomberg-US-on-the-RedChip-Money-ReportR
(0)
•••
Univego
X
Post by
Univego
on Apr 19, 2023 2:56am
Countdown
Only 8 days left!!!! On 5/5/2023, there will be new data from the ongoing P3 trial and a virtual discussion, plus an expert will report on brilaroxazine (RP5063): Reviva
...more
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 29, 2021 1:18pm
RVPH update.....
trading at $5.97 today. What can I say? I'm still waiting for the P.O announcement.......come on.....now fess up !
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 27, 2021 10:32am
RE:Marking new "Strike 2" pivot......
And there you have it folks............after yesterdays action.....sub $7.00 this a.m Cheers !
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 26, 2021 2:28pm
Don't let the green grass fool ya..... !!!!!
Wilson Pickett - Don't Let The Green Grass Fool You - Bing video
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 26, 2021 2:19pm
Marking new "Strike 2" pivot......
which is now $8.03 and has just been breached..... Strike 3 is a tough call but I will go out on a limb and say it's game over sub- $7...... time will tell
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 26, 2021 2:08pm
RE:And now for the raid decent.....
raid*......should read rapid
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 26, 2021 2:06pm
And now for the raid decent.....
JMHO Stay tuned for the P.O announcement...just sayin
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 26, 2021 12:52pm
RE:Trust me......
Covered short obviously......sticking with what I know. C u tomorrow
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 26, 2021 12:22pm
Trust me......
this will not turn out well.... JMHO
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 26, 2021 12:20pm
RE:Make note:
Man of my word....... No position. Wait for the next opportunity now. Cheers !
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 26, 2021 12:12pm
Make note:
I won't let a profit on short turn into a loss. Cheers !
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 26, 2021 12:11pm
RE:Short set up here .... RVPH
LoL.... heading down now......has to hold $7.03 or it could done. Just sayin. Cheers !
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Team spotlight: Q+A: Charlene Duffett, Viridian Metals exploration manager
Freegold Ventures reports results from six additional drill holes at its Golden Summit project
BioVaxys and AI-Guided mRNA Immunotherapy Leader Adiverna Enter Collaboration to Develop Companion Animals Vaccines
Podcasts